← Back to Search

Sleep and Lifestyle Advice Website for Prostate Cancer

N/A
Waitlist Available
Led By Stacy Loeb, MD MSc
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months
Awards & highlights

Study Summary

This trial looks at the effects of sleep, exercise, and diet on prostate cancer.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sleeplessness
Change in Number of Awakenings After Sleep Onset
Change in Pittsburgh Sleep Quality Index (PSQI) Score
+3 more
Secondary outcome measures
Change in Dietary Consumption
Change in device-based moderate-vigorous intensity physical activity (MVPA) minutes per day
Change in device-based step counts per day
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single Arm Prospective StudyExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,711 Total Patients Enrolled
24 Trials studying Prostate Cancer
5,189 Patients Enrolled for Prostate Cancer
New York State Department of HealthOTHER_GOV
34 Previous Clinical Trials
447,047 Total Patients Enrolled
Stacy Loeb, MD MScPrincipal InvestigatorNYU Langone Health

Media Library

Sleep and Lifestyle Advice Website Clinical Trial Eligibility Overview. Trial Name: NCT05318131 — N/A
Prostate Cancer Research Study Groups: Single Arm Prospective Study
Prostate Cancer Clinical Trial 2023: Sleep and Lifestyle Advice Website Highlights & Side Effects. Trial Name: NCT05318131 — N/A
Sleep and Lifestyle Advice Website 2023 Treatment Timeline for Medical Study. Trial Name: NCT05318131 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aim of this experiment?

"This clinical study seeks to observe the Change in Insomnia Severity Index Score over a 3 month period. Secondary objectives, such as assessing device-based step counts per day with ActiLife software and measuring self-reported total physical activity MET-minutes per day using the International Physical Activity Questionnaire short form (IPAQ-SF), will also be taken into account."

Answered by AI

Is recruitment still open for participants in this experiment?

"According to the facts provided on clinicaltrials.gov, this medical study is presently recruiting individuals as of August 31st 2022 - having been posted initially on August 30th 2022."

Answered by AI

How many participants have joined this trial thus far?

"Affirmative, clinicaltrials.gov has information alluding to the fact that this medical experiment is currently recruiting members. This study was originally posted on August 30th 2022 and subsequently modified on August 31st 2022. A total of 50 patients will be recruited from 1 individual site."

Answered by AI
~19 spots leftby Apr 2025